Searchable abstracts of presentations at key conferences in endocrinology

ea0005s32 | Radioiodine Biology in the 21st Century | BES2003

NIS and thyroid cancer

Morris J

Radioiodide therapy of thyroid cancer represents the most effective form of systemic radiotherapy available to the clinician today. The ability of thyroid cancer cells to concentrate iodide is induced by expression in the follicular cell membrane of the sodium iodide symporter, NIS. Some thyroid cancers lack expression of this protein and therefore the ability to concentrate iodide, making them insensitive to 131-I therapy. Several investigators have characterized the expressi...

ea0013p247 | Neuroendocrinology and behaviour (including pituitary) | SFEBES2007

Sleep disorders and response to treatment in the ‘Acromegalic cardiovascular and respiratory outcomes with primary analogue therapy (ACROPAT)’ trial

Webb Alison , Pilsworth Sam , O’Toole Sam , Strey Chris , Ariyaratnam Shaumya , George Emad , Majeed Joohi , Melvin Alison , Morrish Nick , Roland Jonathan , Smith Ian , Wood Diana , Chatterjee Krishna , Simpson Helen , Shneerson John , Gurnell Mark

Respiratory disorders are a major cause of illness and impaired physical function in patients with acromegaly, contributing to 25% of all recorded deaths, with respiratory mortality 3-fold higher than in normal subjects. Sleep apnoea (SA), the phenomenon of recurrent cessation or decrease of airflow to the lungs during sleep, is the commonest reported respiratory complication. Both obstructive (OSA) and central (CSA) sleep apnoeas are known to occur, although the overall preva...

ea0020oc6.4 | Paediatric Endocrinology/Bone | ECE2009

Appearance matters: the impact of perceived altered appearance as a result of Klinefelter's syndrome on psycho-social functioning

Jackson Sue , Morris Marianne

Background: Klinefelter’s syndrome (KS) is a genetic condition affecting men with the potential to severely reduce their testosterone levels and affect their physical appearance. Being a syndrome there are a variety of different symptoms which individuals may experience to a great or lesser extent. While much research has been directed at understanding the cognitive impact of KS much less research has been undertaken considering the psycho-social impact of living with the...

ea0020p563 | Neuroendocrinology, Pituitary and Behaviour | ECE2009

The impact of infertility on the relationship of people with a Pituitary condition

Morris Marianne , Harrison Pascale

Background: Evidence from a Needs Analysis (2006) and Patient Satisfaction Survey (2008) for people with pituitary conditions, suggested infertility was a key yet unexpected problem for the majority of respondents. Being infertile without the co-morbidity of having a pituitary condition confers a huge emotional burden on the couple concerned. The aim of this study was to explore in detail the effects infertility imposed on people with a pituitary condition.<p class="abstex...

ea0019p216 | Neuroendocrinology and behaviour | SFEBES2009

Attribution matters: the impact of Klinefelter’s syndrome on psycho-social functioning

Jackson S , Morris M

Background: Klinefelter’s syndrome (KS) is a genetic condition affecting men with the potential to severely reduce their testosterone levels and affect their physical appearance. Being a syndrome there are a variety of different symptoms, which individuals may experience to a great or lesser extent. While much research has been directed at understanding the cognitive impact of KS much less research has been undertaken considering the psycho-social impact of living with th...

ea0019p235 | Pituitary | SFEBES2009

Dealing with infertility as a consequence of a pituitary condition

Morris M , Harrison P

Background: Evidence from a Needs Analysis (2006) and Patient Satisfaction Survey (2008) for people with pituitary conditions suggested infertility was a key yet unexpected problem for the majority of respondents. Being infertile without the co-morbidity of pituitary condition confers a huge emotional burden on the individual. The aim of this piece of research was to investigate individual’s perceptions of managing infertility following a diagnosis of a pituitary conditio...

ea0011p919 | Thyroid | ECE2006

Withdrawal of alfacalcidol supplements following thyroidectomy: baseline plasma PTH predicts successful outcome

Morris M , Perros P

Permanent hypoparathyroidism is rare after total thyroidectomy. However, our experience is that often patients remain on alfacalcidol and calcium supplements long-term after thyroidectomy.A study was initiated in our centre in 2004, whereby all patients on alfacalcidol or calcium supplements post thyroidectomy underwent a gradual alfacalcidol and calcium reduction programme. Of 57 patients thus enrolled, we report on 22 who were initially on alfacalcidol...

ea0004p70 | Neuroendocrinology and behaviour | SFE2002

Pituitary gonadotrophs in neuronal nitric oxide synthase (nNOS) knockout mice

Fryer E , Morris J

Nitric oxide (NO) is a regulator of pituitary gonadotrophs via local paracrine and autocrine actions. Gonadotrophs express neuronal nitric oxide synthase (nNOS) but the effects of NO on gonadotrophs are controversial and both stimulation and inhibition of LH release has been reported. nNOS -/- mice have reduced fertility, but this is attributed to ovary actions, because no difference was detected in basal or GnRH-stimulated LH release (Klein et al 1998). We have therefore exam...

ea0077p170 | Endocrine Cancer and Late Effects | SFEBES2021

Pituitary metastasis from lung adenocarcinoma presenting with panhypopituitarism

Morris Hannah , Golding Jonathan , Ahmed Fahad

Background: Pituitary metastases are a rare occurrence, accounting for just 0.4% of intracranial metastatic tumours and are most often associated with breast and lung malignancies. The vast majority of lesions are asymptomatic and due to the predilection of metastasis to the posterior lobe of the pituitary gland, clinical presentation with anterior pituitary insufficiency is uncommon and rarely reported in literature.Case summary: A 51-year old male with...

ea0055oc2 | National Clinical Cases | SFEEU2018

Episodic primary aldosteronism associated with a novel gain-of-function mutation in a cell adhesion molecule

Wu Xilin , Garg Sumedha , Brown Morris

Case history: A 46-year-old headmaster with a 10-year history of hypertension presented with a BP of 164/116 mmHg on four antihypertensive drugs. He had occasional headaches, chest ‘aches’, and described one syncopal episode after an ‘exhausting rowing session’. A low plasma renin (routinely measured in our resistant hypertensives) and 26/20 mmHg fall in BP on changing hydrochlorothiazide to amiloride, led to investigations for primary aldosteronism (PA).</...